The aim of the present study was to define subsets of patients suffering from polymyalgia rheumatica, where methotrexate (MTX) up to 20 mg/week might be more effective.
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients
Quartuccio, Luca
Writing – Original Draft Preparation
;Isola, MiriamFormal Analysis
;De Vita, SalvatoreInvestigation
2018-01-01
Abstract
The aim of the present study was to define subsets of patients suffering from polymyalgia rheumatica, where methotrexate (MTX) up to 20 mg/week might be more effective.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
ggi.13460.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Non pubblico
Dimensione
161.77 kB
Formato
Adobe PDF
|
161.77 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
